Real-world use of biologics during the first year of treatment for newly diagnosed Crohn’s disease in Japan: a claims analysis from 2010 to 2021
Use of biologics for treatment of CD within the first year of diagnosis in Japan has remained stable over the past decade. However, there was a shift to a step-up treatment approach, with an increase in use of SCS before biologics over time.
Authors
- Annabelle Yoon (ORCID: https://orcid.org/0009-0000-1188-1382)
- Jun Miyoshi (ORCID: https://orcid.org/0000-0002-6883-1930)
- Tadakazu Hisamatsu (ORCID: https://orcid.org/0000-0002-1178-3536)
- Minoru Matsuura (ORCID: https://orcid.org/0000-0001-9590-2370)
Institutions
- Kyorin University (JP)
- Takeda (Japan) (JP)
Publication Details
- Journal
- Intestinal Research
- Published
- 2025-01-23
- DOI
- https://doi.org/10.5217/ir.2024.00082
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.63
Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare